OEM Customized wholesale Paeoniflorin for Nigeria Factories

OEM Customized wholesale
 Paeoniflorin for Nigeria Factories

Short Description:

A. Basic information 【Product name】 Paeoniflorin 【Source of plant】 Paeonia albiflora Pall 【Active ingredients】 Paeoniflorin 【Specifications】 Paeoniflorin40%,95%;OEM 【Extraction solvent】 Ethanol B. Main functions a) Reduce blood pressure and rheumatoid factor titer, to anti-inflammatory and immunomodulatory action。 b) Inhibits sympathetic nerve excitability, to antispasmodic, analgesic and anticonvulsant。 c) Protect liver...


Product Detail

Product Tags

To become the stage of realizing dreams of our employees! To build a happier, much more united and far more professional team! To reach a mutual profit of our clients, suppliers, the society and ourselves for Antioxidation , Paeoniflorin , Grape Seed Extract , We welcome new and aged shoppers from all walks of daily life to call us for long term business associations and mutual accomplishment!
OEM Customized wholesale Paeoniflorin for Nigeria Factories Detail:

A. Basic information

Product name

Paeoniflorin

Source of plant

Paeonia albiflora Pall

Active ingredients

Paeoniflorin

Specifications

Paeoniflorin40%95%OEM

Extraction solvent

Ethanol

B. Main functions

a) Reduce blood pressure and rheumatoid factor titer, to anti-inflammatory and immunomodulatory action

b) Inhibits sympathetic nerve excitability, to antispasmodic, analgesic and anticonvulsant

c) Protect liver and lowering blood pressure, increase the nutritional blood flow; expand coronary arteries and increases coronary blood flow, preventing platelet aggregation and inhibit cardiac and cerebral vascular diseases

C. Quality key points

Ø Raw material control     SY.png

Ø Residual solvents

D. Quality control and product advantages

Organic raw herbs

QA&QC systemStrictly executing documented procedure prevention management, quality assured.

Technical advantageSharing of professional product identification techniques

Various specifications, OEM accepted

E. Product specifications

Content of active ingredient

Paeoniflorin

Specification

Assayspecification

95%

Item

Testing Standard

Testing method

Character

Appearance

White powder, bitter, sour and astringent

Sensory evaluation

Identification

TLC

confirm

ChP<0502>

HPLC

confirm

ChP<0512>

Assay

Paeoniflorin%

NLT 40%

ChP<0512>

Examination

Loss on drying%

NMT 5.0

ChP<0841>

Ash%

NMT 5.0

ChP<0831>

Heavy metals

LeadPb

NMT 3.0 ppm

ChP<2321>

CadmiumCd

NMT 0.3 ppm

ChP<2321>

MercuryHg

NMT 0.2 ppm

ChP<2321>

ArsenicPb

NMT 2.0 ppm

ChP<2321>

Pesticide residues

Methanol

NMT 100ppm

ChP<0861>

Ethanol

NMT 1000ppm

ChP<0861>

Microorganism

Total aerobic bacteriacfu/g

NMT 1000

ChP<1105>

Mould & Yeastcfu/g

NMY 100

ChP<1105>

Escherichia coli/10g

Not Detected

ChP<1106>

Salmonella/10g

Not Detected

ChP<1106>


Product detail pictures:

OEM Customized wholesale
 Paeoniflorin for Nigeria Factories detail pictures


Our group through specialist training. Skilled expert knowledge, sturdy sense of assistance, to fulfill the provider needs of shoppers for OEM Customized wholesale Paeoniflorin for Nigeria Factories, The product will supply to all over the world, such as: Berlin , Iran , Chicago , Strong infrastructure is the want of any organization. We've been backed with a robust infrastructural facility that enables us to manufacture, store, quality check and dispatch our merchandise worldwide. To maintain smooth work flow, we've got sectioned our infrastructure into a number of departments. All these departments are functional with latest tools, modernized machines and equipment. Owing to which, we're able to accomplish voluminous production without compromising on the quality.



  • Tim Miller, Ph.D., President & CEO
    Dallas, TX
    (NASDAQ: ABEO)

    Abeona Therapeutics develops and delivers gene therapy and plasma-based products for severe and life-threatening rare diseases. Abeona’s lead programs are AB0-101 (AA9 NAGLU) and ABO-102 (scAAV9 SGSH), adeno-associated virus (AAV)-based gene therapies for Sanfilippo syndrome (MPS IIIB and IIIA). In collaboration with patient advocacy groups, researchers and clinicians, the Company is anticipated to commence clinical trials in 2015. Abeona is also developing ABO-201 (scAAV9 CLN3) gene therapy for juvenile Batten disease (JBD); and ABO-301 (AAV FANCC) for Fanconi anemia (FA) disorder using a novel CRISPR/Cas9-based gene editing approach to a gene therapy program for rare blood diseases. In addition, the Company is also developing rare plasma protein therapies including SDF Alpha™ (alpha-1 protease inhibitor) for inherited COPD using our proprietary SDF™ (Salt Diafiltration) ethanol-free process. www.abeonatherapeutics.com

    Send your message to us:

    INQUIRY NOW
    • * CAPTCHA: Please select the Flag

    Related Products

    INQUIRY NOW
    • * CAPTCHA: Please select the Plane

    WhatsApp Online Chat !